Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas;Apport de l'imagerie de spectroscopie de résonance magnétique du proton et des autres imageries métaboliques à la définition des volumes cibles de radiothérapie des tumeurs gliales de l'adulte et de l'enfant

Cancer/Radiotherapie

Volumn 13, Issue 6-7, 2009, Pages 556-561

  Laprie, A ^a,b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b CHU PURPAN   (France)

Author keywords

Brain; Children; Diffusion MRI; Glioblastoma; Glioma; MR spectroscopy; Perfusion MRI; PET; Positron emission tomography; Proton MR spectroscopic imaging; Radiotherapy

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLTYROSINE; METHIONINE C 11; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; WATER O 15;

ADULT; CANCER RADIOTHERAPY; CANCER RELAPSE; CELL METABOLISM; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DOSIMETRY; GLIOMA; HUMAN; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SHORT SURVEY; SPIN LABELING; TREATMENT PLANNING; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; GLIOBLASTOMA; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW;

ADULT; BRAIN NEOPLASMS; CHILD; GLIOBLASTOMA; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 70350743336     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.07.003     Document Type: Short Survey

References (52)

1. Bruehlmeier M., Roelcke U., Schubiger P.A., and Ametamey S.M. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. J Nucl Med 45 (2004) 1851-1859
2. Catalaa I., Henry R., Dillon W.P., Graves E.E., McKnight T.R., Lu Y., et al. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 19 (2006) 463-475
3. de Wit M.C., de Bruin H.G., Eijkenboom W., Sillevis Smitt P.A., and van den Bent M.J. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63 (2004) 535-537
4. Eschmann S.M., Paulsen F., Reimold M., Dittmann H., Welz S., Reischl G., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
5. Floeth F.W., Pauleit D., Sabel M., Reifenberger G., Stoffels G., Stummer W., et al. 18FFET PET differentiation of ring-enhancing brain lesions. J Nucl Med 47 (2006) 776-782
6. Galanaud D., Nicoli F., Le Fur Y., Roche P., Confort-Gouny S., Dufour H., et al. Apports de la spectrométrie par résonance magnétique dans le diagnostic de nature des processus occupants intracrânien. Ann Med Interne (Paris) 153 (2002) 491-498
7. Girard N., Wang Z.J., Erbetta A., Sutton L.N., Phillips P.C., Rorke L.B., et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology 40 (1998) 121-125
8. Grand S., Lefournier V., Krainik A., Bessou P., Tropres I., Chabardes S., et al. Imagerie de perfusion: principes et applications cliniques. J Radiol 88 (2007) 444-471
9. Graves E.E., Nelson S.J., Vigneron D.B., Chin C., Verhey L., McDermott M., et al. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46 (2000) 319-326
10. Haas-Kogan D.A., Banerjee A., Kocak M., Prados M.D., Geyer J.R., Fouladi M., et al. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol 10 (2008) 341-347
11. Harris L.M., Davies N.P., Macpherson L., Lateef S., Natarajan K., Brundler M.A., et al. Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomas. Eur J Cancer 44 (2008) 2640-2647
12. Henry R.G., Vigneron D.B., Fischbein N.J., Grant P.E., Day M.R., Noworolski S.M., et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21 (2000) 357-366
13. Hochberg F.H., and Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 30 (1980) 907-911
14. Kantor G., Laprie A., Huchet A., Loiseau H., Dejean C., and Mazeron J.J. Radiothérapie des tumeurs gliales : techniques et indications. Cancer Radiother 12 (2008) 687-694
15. Krishnan A.P., Asher I.M., Davis D., Okunieff P., and O'Dell W.G. Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors. Int J Radiat Oncol Biol Phys 71 5 (2008) 1553-1562
16. Laprie A., Catalaa I., Cassol E., McKnight T.R., Berchery D., Marre D., et al. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study. Int J Radiat Oncol Biol Phys 70 (2008) 773-781
17. Laprie A., Pirzkall A., Haas-Kogan D.A., Cha S., Banerjee A., Le T.P., et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 20-31
18. Le Bas J.F., Grand S., Krainik A., Lefournier V., Tropres I., and Remy C. IRM de perfusion des tumeurs cérébrales. J Radiol 87 (2006) 807-821
19. Lichy M.P., Henze M., Plathow C., Bachert P., Kauczor H.U., and Schlemmer H.P. Metabolic imaging to follow stereotactic radiation of gliomas - the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 176 (2004) 1114-1121
20. Marcus K.J., Astrakas L.G., Zurakowski D., Zarifi M.K., Mintzopoulos D., Poussaint T.Y., et al. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol 30 (2007) 651-657
21. McKnight T.R., dem Bussche M.H., Vigneron D.B., Lu Y., Berger M.S., McDermott M.W., et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97 (2002) 794-802
22. Moffat B.A., Chenevert T.L., Lawrence T.S., Meyer C.R., Johnson T.D., Dong Q., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102 (2005) 5524-5529
23. Narayana A., Chang J., Thakur S., Huang W., Karimi S., Hou B., et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 80 953 (2007) 347-354
24. Narayana A., Chang J., Thakur S., Huang W., Karimi S., Hou B., et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 80 (2007) 347-354
25. Narayana A., Yamada J., Berry S., Shah P., Hunt M., Gutin P.H., et al. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys 64 (2006) 892-897
26. Nwokedi E.C., DiBiase S.J., Jabbour S., Herman J., Amin P., and Chin L.S. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50 (2002) 41-46
27. Oh J., Henry R.G., Pirzkall A., Lu Y., Li X., Catalaa I., et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetyl-aspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19 (2004) 546-554
28. Oppenheim C., Ducreux D., Rodrigo S., Hodel J., Tourdias T., Charbonneau F., et al. Imagerie en tenseur de diffusion et tractographie de l'encéphale et de la moelle. J Radiol 88 (2007) 510-520
29. Padhani A.R., Krohn K.A., Lewis J.S., and Alber M. Imaging oxygenation of human tumours. Eur Radiol 17 (2007) 861-872
30. Panigrahy A., Nelson Jr. M.D., Finlay J.L., Sposto R., Krieger M.D., Gilles F.H., et al. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 10 (2008) 32-44
31. Park I., Tamai G., Lee M.C., Chuang C.F., Chang S.M., Berger M.S., et al. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys 69 2 (2007) 381-389
32. Pauleit D., Floeth F., Hamacher K., Riemenschneider M.J., Reifenberger G., Muller H.W., et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128 (2005) 678-687
33. Pirzkall A. MR-Spectroscopy: potential for brain tumor diagnosis and guiding therapy. In: Black P., and Loeffler J.S. (Eds). Cancer of the nervous system. (2004), Lippincott Williams & Wilkins, Philadelphia
34. Pirzkall A., Li X., Oh J., Chang S., Berger M.S., Larson D.A., et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59 (2004) 126-137
35. Pirzkall A., McKnight T.R., Graves E.E., Carol M.P., Sneed P.K., Wara W.W., et al. MRspectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50 (2001) 915-928
36. Pirzkall A., Nelson S.J., McKnight T.R., Takahashi M.M., Li X., Graves E.E., et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 53 (2002) 1254-1264
37. Poptani H., Gupta R.K., Roy R., Pandey R., Jain V.K., and Chhabra D.K. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 16 (1995) 1593-1603
38. Sabatier J., Tremoulet M., Ranjeva J.P., Manelfe C., Berry I., Gilard V., et al. Contribution of in vivo 1H spectroscopy to the diagnosis of deep-seated brain abscess. J Neurol Neurosurg Psychiatry 66 (1999) 120-121
39. Saraswathy S., Crawford F.W., Lamborn K.R., Pirzkall A., Chang S., Cha S., et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol 91 (2009) 69-81
40. Schlemmer H.P., Bachert P., Herfarth K.K., Zuna I., Debus J., and van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 22 (2001) 1316-1324
41. Shenouda G., Souhami L., Podgorsak E.B., Bahary J.P., Villemure J.G., Caron J.L., et al. Radiosurgery and accelerated radiotherapy for patients with glioblastoma. Can J Neurol Sci 24 (1997) 110-115
42. Shrieve D.C., Alexander III E., Black P.M., Wen P.Y., Fine H.A., Kooy H.M., et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90 (1999) 72-77
43. Shukla-Dave A., Gupta R.K., Roy R., Husain N., Paul L., Venkatesh S.K., et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging 19 (2001) 103-110
44. Stadlbauer A., Prante O., Nimsky C., Salomonowitz E., Buchfelder M., Kuwert T., et al. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18Ffluoroethyl)- L-tyrosine PET and proton magnetic resonance spectroscopic imaging. J Nucl Med 49 (2008) 721-729
45. Taal W., Brandsma D., de Bruin H.G., Bromberg J.E., Swaak-Kragten A.T., Eijkenboom W.M., et al. The incidence of pseudoprogression in a cohort of malignant glioma patients treated with chemoradiation with temozolomide. 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 25 18S (2007) 2007-2009
46. Turner C.D., Chi S., Marcus K.J., MacDonald T., Packer R.J., Poussaint T.Y., et al. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 82 (2007) 95-101
47. Tzika A.A., Astrakas L.G., Zarifi M.K., Petridou N., Young-Poussaint T., Goumnerova L., et al. Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 45 (2003) 1-10
48. Tzika A.A., Cheng L.L., Goumnerova L., Madsen J.R., Zurakowski D., Astrakas L.G., et al. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 96 (2002) 1023-1031
49. Tzika A.A., Zarifi M.K., Goumnerova L., Astrakas L.G., Zurakowski D., Young-Poussaint T., et al. Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR Am J Neuroradiol 23 (2002) 322-333
50. Tzika A.A., Zurakowski D., Poussaint T.Y., Goumnerova L., Astrakas L.G., Barnes P.D., et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology 43 (2001) 169-177
51. Weybright P., Sundgren P.C., Maly P., Hassan D.G., Nan B., Rohrer S., et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 185 (2005) 1471-1476
52. Zeng Q.S., Li C.F., Liu H., Zhen J.H., and Feng D.C. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys 68 (2007) 151-158